Hydrocortisone; tetracycline hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for hydrocortisone; tetracycline hydrochloride and what is the scope of patent protection?
Hydrocortisone; tetracycline hydrochloride
is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for hydrocortisone; tetracycline hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 2 |
DailyMed Link: | hydrocortisone; tetracycline hydrochloride at DailyMed |
Recent Clinical Trials for hydrocortisone; tetracycline hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Alphacait, LLC | Phase 2 |
Federal University of São Paulo | Phase 4 |
See all hydrocortisone; tetracycline hydrochloride clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for hydrocortisone; tetracycline hydrochloride
US Patents and Regulatory Information for hydrocortisone; tetracycline hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lederle | ACHROMYCIN | hydrocortisone; tetracycline hydrochloride | OINTMENT;OPHTHALMIC | 050272-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |